Press Releases Press Releases Year None20232022202120202019201820172016201520142013201120102009200820072005 March 28, 2023 Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features PDF Version March 1, 2023 Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update PDF Version February 14, 2023 Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast PDF Version February 8, 2023 Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference PDF Version January 3, 2023 Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference PDF Version
March 28, 2023 Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features PDF Version
March 1, 2023 Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update PDF Version
February 14, 2023 Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast PDF Version
February 8, 2023 Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference PDF Version
January 3, 2023 Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference PDF Version
